NewAmsterdam Pharma Company N.V. (NAMS) Stock Forecast

Nov 24, 2022 · The 5 analysts with 12-month price forecasts for NAMS stock have an average target of 41.6, with a low estimate of 36 and a high estimate of 48. The average target predicts …

CouponFollow Extension

$41.33
OFF

Newamsterdam Pharma Co Nv Stock Forecast, Predictions & Price …

3 weeks from now

On average, Wall Street analysts predict. that Newamsterdam Pharma Co Nv's share price could reach $41.33 by Jan 28, 2026. The average Newamsterdam Pharma Co Nv stock price …

wallstreetzen.com

$30
OFF

What Is The Current Price Target And Forecast For NewAmsterdam …

3 weeks from now

6 days ago · The forecasts for NewAmsterdam Pharma Company N.V. (NAMS) range from a low of $30 to a high of $48. The average price target represents a increase of $88.54 from the last …

zacks.com

$32.67
OFF

NewAmsterdam Pharma (NASDAQ:NAMS) Stock, Analyst Ratings, …

3 weeks from now

NewAmsterdam Pharma Co NV has a consensus price target of $32.67 based on the ratings of 11 analysts. The high is $48 issued by HC Wainwright & Co. on January 14, 2025 . The low is …

benzinga.com

$39.83
OFF

Where NewAmsterdam Pharma Stands With Analysts - Nasdaq

3 weeks from now

Dec 30, 2024 · In the assessment of 12-month price targets, analysts unveil insights for NewAmsterdam Pharma, presenting an average target of $39.83, a high estimate of $48.00, …

nasdaq.com

$707400
OFF

Consensus NewAmsterdam Pharma Company N.V. Nasdaq

3 weeks from now

Oct 3, 2024 · Newamsterdam Pharma Co Insider Sold Shares Worth $707,400, According to a Recent SEC Filing ... Evolution of the Target Price: NewAmsterdam Pharma Company N.V. …

marketscreener.com

$40.88
OFF

Deep Dive Into NewAmsterdam Pharma Stock: Analyst …

3 weeks from now

Jan 25, 2025 · Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $40.88, a high estimate of $48.00, and a low estimate …

sahmcapital.com

$43.83
OFF

RBC Capital Sticks To Their Buy Rating For NewAmsterdam Pharma …

3 weeks from now

6 days ago · NewAmsterdam Pharma Company has an analyst consensus of Strong Buy, with a price target consensus of $43.83. See the top stocks recommended by analysts >> The …

businessinsider.com

$35.00
OFF

NewAmsterdam Pharma (NASDAQ:NAMS) Trading Up 4.1

3 weeks from now

2 days ago · Scotiabank boosted their price target on NewAmsterdam Pharma from $35.00 to $47.00 and gave the company a "sector outperform" rating in a report on Wednesday, …

marketbeat.com

95%
OFF

What 4 Analyst Ratings Have To Say About NewAmsterdam Pharma

3 weeks from now

Nov 7, 2024 · This current average reflects an increase of 0.95% from the previous average price target of $34.67. ... value of NewAmsterdam Pharma's stock. This comparison reveals trends …

nasdaq.com

$2
OFF

NewAmsterdam Pharma's SWOT Analysis: Obicetrapib Stock Shows …

3 weeks from now

5 days ago · NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a biopharmaceutical company with a market capitalization of $2.3 billion focused on developing cardiovascular …

investing.com

$33.75
OFF

Expert Ratings For NewAmsterdam Pharma - Nasdaq

3 weeks from now

Sep 23, 2024 · Analysts have set 12-month price targets for NewAmsterdam Pharma, revealing an average target of $33.75, a high estimate of $37.00, and a low estimate of $31.00.

nasdaq.com

FAQs about NewAmsterdam Pharma Company N.V. (NAMS) Stock Forecast Coupon?

What are the target prices for newamsterdam pharma's stock?

4 equities research analysts have issued 12 month target prices for NewAmsterdam Pharma's stock. Their NAMS share price forecasts range from $19.00 to $24.00. On average, they predict the company's share price to reach $21.67 in the next year. This suggests a possible upside of 50.7% from the stock's current price. ...

What is the upside for newamsterdam Pharma?

According to analysts' consensus price target of $21.67, NewAmsterdam Pharma has a forecasted upside of 49.7% from its current price of $14.47. NewAmsterdam Pharma has only been the subject of 1 research reports in the past 90 days. ...

Is newamsterdam Pharma (NAMS) a great growth stock in 2023?

NewAmsterdam Pharma's stock was trading at $10.90 on January 1st, 2023. Since then, NAMS stock has increased by 31.9% and is now trading at $14.38. View the best growth stocks for 2023 here. When is NewAmsterdam Pharma's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, June 30th 2023. ...

Who is newamsterdam Pharma?

NewAmsterdam Pharma Co. NV is a clinical-stage biopharmaceutical company, which engages in the development of oral, non-statin medicine for patients at high risk of cardiovascular disease with residual elevation of low-density lipoprotein cholesterol. ...

How much does newamsterdam Pharma make?

NewAmsterdam Pharma (NASDAQ:NAMS) has a market capitalization of $255.25 million and generates $102.74 million in revenue each year. How can I contact NewAmsterdam Pharma? NewAmsterdam Pharma's mailing address is TWO UNION SQUARE 601 UNION STREET SUITE 3200, SEATTLE WA, 98101. ...